Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective

Eur Respir J. 2010 Apr;35(4):936-8; author reply 938-40. doi: 10.1183/09031936.00132009.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / adverse effects*
  • Anti-Infective Agents / administration & dosage
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / adverse effects*
  • Drug Resistance, Bacterial*
  • Drug Resistance, Multiple*
  • Female
  • Humans
  • India
  • Linezolid
  • Male
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / adverse effects*
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Acetamides
  • Anti-Infective Agents
  • Antitubercular Agents
  • Oxazolidinones
  • Linezolid